NICE recommends Stelara (ustekinumab) for the treatment of active psoriatic arthritis

Janssen has announced that the National Institute for Health and Clinical Excellence (NICE), has recommended Stelara® (ustekinumab) in its Final Appraisal Determination (FAD)1 as...